Jump to main content
Jump to site search
Book cover

Proteinases as Drug Targets Editor: Ben Dunn



Buy hardback £132.99 *
Add to pick and choose £398.97
* Exclusive of taxes
This book contains 292 pages.
Print publication date: 30 Nov 2011
Copyright year: 2012
Print ISBN: 978-1-84973-049-5
PDF eISBN: 978-1-84973-315-1
Citation:

About this book

This book provides vital information on a class of enzymes that have emerged as key drug targets in a number of human diseases, including HIV/AIDS, Hypertension, Cancer, and Alzheimer's disease. There is a gap in information due to the lack of recent international meetings on this subject and, thus, no recent summaries of current research have emerged. The book contains up-to-date information, especially with the genomics revolution of recent years, and includes new proteomics techniques. The story of this enzyme family also includes the most significant efforts in computer-aided drug discovery and structure-based drug design. With contributions from experts in the field, the book is edited by the previous President of the International Proteolysis Society, whose academic career in the field has spanned 35 years.

From the book series:
RSC Drug Discovery

Author information

Ben M Dunn is a Distinguished Professor of Biochemistry & Molecular Biology at the Department of Biochemistry & Molecular Biology, University of Florida, USA. He is also an NIH-funded Investigator and is currently supported by a MERIT award for the NIAID. He was President of the International Proteolysis Society from 2003-2005 and is currently President of the American Peptide Society.